Temporal and environmental effects on quinpirole-induced biphasic locomotion in rats

被引:33
|
作者
VanHartesveldt, C
机构
[1] Psychology Department, University of Florida, Gainesville
关键词
dopamine; locomotion; quinpirole; ontogeny; rat;
D O I
10.1016/S0091-3057(97)00332-8
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The dopamine D-2/D-3 agonist quinpirole induces suppression of locomotor activity at low doses, and suppression followed by activation at high doses when given to rats of 30 days of age and older that are immediately placed in activity monitors. The duration of suppression is longer and the level of activation is lower at 60 than at 30 days of age, suggesting that the mechanism responsible for the suppression may play a role in the lesser activation in the older rats. However, habituation limits the ability to measure the duration of locomotor suppression. Therefore, 0, 0.2, or 0.2 mg/kg quinpirole was injected SC either 30, 60, or 120 min before placing male or female rats of 30 or 60 days of age in activity monitors for 30 min. At both ages, both doses of quinpirole suppressed activity when the animal was placed in the monitor 30 or 60 min after injection; at 60 days the drug also suppressed activity at 120 min after injection. Previously, 0.2 mg/kg quinpirole elicited locomotor activity 60 min after injection in rats placed immediately in activity monitors at both ages. Thus, not only time after injection but novelty of the environment are critical factors in the expression of locomotor suppression or activation in response to quinpirole. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:955 / 960
页数:6
相关论文
共 50 条
  • [31] Opposite roles of dopamine and orexin in quinpirole-induced excessive drinking: a rat model of psychotic polydipsia
    Michele S. Milella
    Francesca Passarelli
    Lorenza De Carolis
    Chiara Schepisi
    Paola Nativio
    Sergio Scaccianoce
    Paolo Nencini
    Psychopharmacology, 2010, 211 : 355 - 366
  • [32] ENVIRONMENTAL AND BEHAVIORAL COMPONENTS OF SENSITIZATION INDUCED BY THE DOPAMINE AGONIST QUINPIROLE
    SZECHTMAN, H
    TALANGBAYAN, H
    EILAM, D
    BEHAVIOURAL PHARMACOLOGY, 1993, 4 (04): : 405 - 410
  • [33] Glutamate mGlu5 receptor antagonist, MPEP, reduces the quinpirole-induced compulsive-like checking in rats
    Gok, Sule
    Demet, Mehmet Murat
    Ozturk, Zeynep
    JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, 2017, 15 : 13 - 18
  • [34] Trace amine-associated receptor 1 agonists RO5263397 and RO5166017 attenuate quinpirole-induced yawning but not hypothermia in rats
    Siemian, Justin N.
    Zhang, Yanan
    Li, Jun-Xu
    BEHAVIOURAL PHARMACOLOGY, 2017, 28 (07): : 590 - 593
  • [35] Haloperidol both prevents and reverses quinpirole-induced nonregulatory water intake, a putative animal model of psychogenic polydipsia
    Amato, Davide
    Stasi, Maria Antonietta
    Borsini, Franco
    Nencini, Paolo
    PSYCHOPHARMACOLOGY, 2008, 200 (02) : 157 - 165
  • [36] Haloperidol both prevents and reverses quinpirole-induced nonregulatory water intake, a putative animal model of psychogenic polydipsia
    Davide Amato
    Maria Antonietta Stasi
    Franco Borsini
    Paolo Nencini
    Psychopharmacology, 2008, 200 : 157 - 165
  • [37] Role of the renin-angiotensin system in the compensation of quinpirole-induced blood pressure decrease
    Luippold, G
    Max, A
    Albinus, M
    Osswald, H
    Mühlbauer, B
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 (05) : 427 - 433
  • [38] Role of the renin-angiotensin system in the compensation of quinpirole-induced blood pressure decrease
    Gerd Luippold
    Alexander Max
    Margitta Albinus
    Hartmut Osswald
    Bernd Mühlbauer
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2003, 367 : 427 - 433
  • [39] EFFECTS OF ADMINISTRATION OF DOPAMINE-D2 AGONIST QUINPIROLE ON EXPLORATORY LOCOMOTION
    MOGENSON, GJ
    WU, M
    BRAIN RESEARCH, 1991, 551 (1-2) : 216 - 220
  • [40] A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats
    K. E. Culver
    J. M. Rosenfeld
    H. Szechtman
    Psychopharmacology, 2000, 151 : 202 - 210